resistell
Resistell is a antibiotic resistance test.
Total raised
€12M
€11,650,872
Funding rounds
2
Investors
6
distinct backers
Active since
2019-09
latest 2022-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood39
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 8y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-20 | Series B | €8.6M | Launchpad Capital,EIC Fund,OCCIDENT,Private Investors,Trumpf Venture,Zürcher Kantonalbank | View deal → |
| 2019-10-01 | Series A | €3.0M | OCCIDENT | View deal → |
Related news
- Resistell raises CHF8.5 million to bring its first product to the marketstartupticker.ch · 2022-12
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy